Skip to the content

KD&A - Regulatory Consultants for Medical and IVD devices

kdent@kdas.com.au
logo mainlogo darklogo light
  • About Us
    • About Us
    • What our Clients Say
    • Frequently Asked Questions
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
    • Our Clients
  • News
  • Useful Links
Get In Touch
logo main
  • About Us
    • What our Clients Say
    • Frequently Asked Questions
    • Useful Links
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
  • Latest News
  • Contact Us

Australian Medical Device Regulatory Framework Tag

16
Jan
EUFDARegulatory ChangesTGA

KD&A – How Can We Help you?

KD&A provide expert medical device and IVD regulatory guidance to help launch products and access new markets. Our services include regulatory strategy, product registration for Au

Read More
Share
30
Sep
EURegulatory Changes

TGA Release Update Regarding Proposed Regulatory Framework Reforms

The European Commission has finally issued it’s much awaited draft regulation on e-labelling, the final version of which is expected to be adopted by 14 December and come into fo

Read More
Share
11
Sep
FDARegulatory Changes

US Food and Drug Administration (FDA) Issue New Regulatory Guidance

The FDA has issued a new guidance to manufacturers detailing when to submit a new 510(k) for changes or modifications made to that manufacturer’s previously cleared medical devic

Read More
Share
18
Jul
Regulatory ChangesTGA

Harmonisation for Australia and NZ on the Horizon

Positive news for therapeutic goods manufacturers as the Australian and New Zealand Governments agree to resume plans for a joint scheme for regulation of therapeutic goods. The jo

Read More
Share

Posts pagination

01 02
News Categories
  • EU
  • FDA
  • Regulatory Changes
  • Research
  • Software
  • Technology
  • TGA
  • Uncategorized
Latest Articles
March 20, 2025
Understanding Requirements for Medical Devices Containing Medicinal, Microbial, Recombinant, or Animal Origin Substances
February 13, 2025
TGA Recall Reforms: A Closer Look at the PRAC
December 6, 2024
KD&A Can Help You From the Start – Medical Devices Steps to Market
Tags

Australia Australian Medical Device Regulatory Framework European Union Manufacturer's Evidence Medical Device Medical Device Regulations Medicinal Substances Regulatory Changes Regulatory Compliance Regulatory Requirements Regulatory Strategy TGA

  • What We Do
  • Who We Help
  • What our Clients Say
+ 61 411 101 392
kdent@kdas.com.au

Get our latest expert updates to your inbox

KD&A provides expert regulatory consulting service to medical device and IVD companies selling on Australian and International markets.

    Contact us:
    kdent@kdas.com.au
    +61 411 101 392
    Our address:
    Level 3, Suite 301,
    27 Belgrave Street,
    Manly NSW, Australia
    Our social:
    Terms and conditions
    Privacy policy
    © 2025 KD&A Pty Ltd
    w

    Lorem ipsum dolor sit amet, consectetur adipiscing elit eiusmod tempor

    w
    leroux@qodeinteractive.com